Nasdaq· Pharmaceutical Preparations· Inc. E9· CIK 0001779578

BGM

BGM Group Ltd.
$9.34 ▲ +19.44%
Prev close $7.82
High Impact Filing (7/10) Biotech & Drug Discovery
Snapshot
The big-picture read on BGM right now — valuation, ownership and activity at a glance.
SEC Reports
4
Price chart 30d +10.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 0 bullish, 4 bearish, 0 mixed, 0 neutral · avg impact 7.3/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 2, 2026
trading_halt
Halt Resumed: BGM — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-02T13:37:02.000Z | Resumed 2026-10-02T13:42:02.000Z
Oct 2, 2026
trading_halt
Trading Halt: BGM — LUDP (Volatility Trading Pause)
BGM Group Ltd. Class A Ord Shs | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 1, 2026
trading_halt
Halt Resumed: BGM — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-01T19:27:38.000Z | Resumed 2026-10-01T19:37:38.000Z
Oct 1, 2026
trading_halt
Trading Halt: BGM — LUDP (Volatility Trading Pause)
BGM Group Ltd. Class A Ord Shs | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 1, 2026
trading_halt
Halt Resumed: BGM — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-01T17:30:55.000Z | Resumed 2026-10-01T17:40:56.000Z
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.00$0.00–$0.00———$0.0B—
Next Q$0.00$0.00–$0.00———$0.0B—
Current FY$0.00$0.00–$0.00———$0.0B—
Next FY$0.00$0.00–$0.00———$0.0B—
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BGM.
Shares short
60,294
Settlement Sep 15, 2026
Change vs prior
-64.6%
Semi-monthly cycle
Days to cover
1.1
At avg daily volume
Of shares outstanding
≈0.0%
Estimate — not % of float
HaltedCodeReasonStatus
Oct 2, 2026LUDPVolatility PauseResumed
Oct 1, 2026LUDPVolatility PauseResumed
Oct 1, 2026LUDPVolatility PauseResumed
Oct 1, 2026LUDPVolatility PauseResumed
Sep 30, 2026T3Resumption ScheduledResumed
All BGM filing & press-release reports (4)